PMC:7594251 / 103401-103732
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T21 | 34-42 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T22 | 140-144 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T23 | 250-254 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T24 | 283-287 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T25 | 322-326 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T30 | 140-144 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T31 | 250-254 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T32 | 283-287 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T33 | 322-326 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T50928 | 34-42 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T73305 | 48-55 | Chemical | denotes | ligands | http://purl.obolibrary.org/obo/CHEBI_52214 |
T694 | 63-72 | Chemical | denotes | molecules | http://purl.obolibrary.org/obo/CHEBI_25367 |
T6431 | 156-160 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T686 | 0-179 | Sentence | denotes | The interactions between targets (proteins) and ligands (small molecules) can be analyzed independently of the biological systems by using ‘cell-based’ NMR drug design approaches. |
T687 | 180-331 | Sentence | denotes | Three basic approaches [409] are as follows: (1) Compound-detected in-cell NMR, (2) Target-detected in-cell NMR, and (3) Reporter-detected in-cell NMR. |